EQUITY INTEREST PURCHASE AGREEMENT by and among CERECOR INC., TRx PHARMACEUTICALS, LLC, THE SELLERS NAMED HEREIN and RANDAL JONES AND ROBERT MOSCATO (SOLELY FOR PURPOSES OF SECTION 6.2 HEREOF)Equity Interest Purchase Agreement • November 17th, 2017 • Cerecor Inc. • Pharmaceutical preparations • North Carolina
This EQUITY INTEREST PURCHASE AGREEMENT, dated as of November 17, 2017 (the “Agreement”), is by and among Cerecor Inc., a Delaware corporation (“Purchaser”), TRx Pharmaceuticals, LLC, a North Carolina limited liability company (the “Company”), the members of the Company listed on the signature pages hereof (each a “Seller” and collectively, the “Sellers”), and, solely for purposes of Section 6.2 hereof, Randal Jones and Robert Moscato (the “Owners” and, together with the Sellers, the “Restricted Parties”).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among CERECOR INC., ZPC MERGER CORP. ZYLERA PHARMA CORP. ZYLERA PHARMACEUTICALS, LLC and THE SELLERS NAMED HEREINAgreement and Plan of Merger • November 17th, 2017 • Cerecor Inc. • Pharmaceutical preparations • North Carolina
This AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, dated as of November 17, 2017 (the “Agreement”), is by and among Cerecor Inc., a Delaware corporation (“Parent”), ZPC Merger Corp., a North Carolina corporation (“Merger Sub,” and collectively with Parent, “Purchaser”), Zylera Pharma Corp., a North Carolina corporation (the “Company”), Zylera Pharmaceuticals, LLC, a North Carolina limited liability company and the sole shareholder of the Company (the “Shareholder”), and the ultimate entity owners of the Company listed on the signature pages hereof (each a “Seller” and collectively, the “Sellers”).
